Global ELISA Diagnostic Tests Market (2024 Edition): Analysis By Test Type (Sandwich ELISA, Indirect ELISA, Competitive ELISA, Others Types), By Application, By End Users, By Region, By Country: Market Insights and Forecast (2020-2030)

Global ELISA Diagnostic Tests Market (2024 Edition): Analysis By Test Type (Sandwich ELISA, Indirect ELISA, Competitive ELISA, Others Types), By Application, By End Users, By Region, By Country: Market Insights and Forecast (2020-2030)

Executive Summary

Azoth Analytics has released a research report titled “Global ELISA Diagnostic Tests Market (2024 Edition)” which provides an analysis of the Global ELISA Diagnostic Tests industry in terms of market segmentation By Test Type (Sandwich ELISA, Indirect ELISA, Competitive ELISA, Other Types), By Application (Autoimmune diseases, Infectious Diseases, Cancer Diagnosis, Other Applications), By End Users (Human, Veterinary) for the historical period of 2020-2023, the estimates of 2024 and the forecast period of 2025-2030.

The report analyses the ELISA Diagnostic Tests Market by Region (Americas, Europe, Asia Pacific, Middle East & Africa) and 10 Countries (United States, Canada, Germany, United Kingdom, France, Italy, Spain, China, Japan, India). The Global ELISA Diagnostic Tests market showcased growth at a CAGR of 5.88% during 2020-2023. The market was valued at USD 1525.98 Million in 2023 which is expected to reach USD 2437.04 Million in 2030.

ELISA diagnostic tests market is experiencing robust growth, driven by advancements in healthcare infrastructure, the rising prevalence of infectious and chronic diseases, and the increasing need for cost-effective diagnostic solutions.

The global ELISA diagnostics market is projected to grow significantly, with its adoption driven by the increasing burden of diseases such as HIV, hepatitis, and autoimmune conditions. The test's reliability, sensitivity, and adaptability to various sample types make it a preferred choice in clinical and research settings.

America leads the market due to advanced healthcare infrastructure and government funding, while Europe follows with strong R&D capabilities and healthcare initiatives. Emerging markets in Asia-Pacific and the Middle East and Africa are witnessing accelerated growth, spurred by improved healthcare access and rising awareness of early disease detection.

Scope of the Report:

• The report analyses the ELISA Diagnostic Tests Market by Value (USD Million).
• The report analyses the ELISA Diagnostic Tests Market by Region (Americas, Europe, Asia Pacific, Middle East & Africa) and 10 Countries (United States, Canada, Germany, United Kingdom, France, Italy, Spain, China, Japan, India).
• The report presents the analysis of ELISA Diagnostic Tests Market for the historical period of 2020-2023, the estimated year 2024 and the forecast period of 2025-2030.
• The report analyses the ELISA Diagnostic Tests Market By Test Type (Sandwich ELISA, Indirect ELISA, Competitive ELISA, Other Types)
• The report analyses the ELISA Diagnostic Tests Market By Application (Autoimmune diseases, Infectious Diseases, Cancer Diagnosis, Other Applications).
• The report analyses the ELISA Diagnostic Tests Market By End Users (Human, Veterinary).
• The key insights of the report have been presented through the frameworks of SWOT and Porter’s Five Forces Analysis. Also, the attractiveness of the market has been presented by region, By Test Type, By Application and By End Users.
• Also, the major opportunities, trends, drivers, and challenges of the industry has been analyzed in the report.
• The report tracks competitive developments, strategies, mergers and acquisitions and new product development. The companies analyzed in the report include QIAGEN, F. Hoffmann-La Roche AG, PerkinElmer Inc., Abbott Laboratories, Thermo Fisher Scientific, Becton, Dickinson and Company, Danaher Corporation Bio-Rad Laboratories, Inc., Enzo Life Sciences, Inc. Innovative Diagnostics SAS.